BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...

BOTHELL – Ekos Corp., which has spent more than a decade inventing ultrasound-enhanced catheters that can quickly break up blood clots, is ready to sell the device to doctors around the world. The ...

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has been acquired by British pharmaceutical company BTG for $180 million. The ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE:BTG)), announced the publication of results of the SEATTLE II trial in the JACC: Cardiovascular ...

BOTHELL, Wash.-- EKOS Corporation announced today the EKOS EkoSonic® Endovascular System is the first endovascular device approved for the treatment of pulmonary embolism (PE). The EkoSonic® System, ...

IRMO, SC (WIS) - A 36-year-old Irmo woman started having shortness of breath. That developed into chest pains and dizziness. A CT scan revealed a life-threatening health situation - a blood clot.

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...